Universal tranexamic acid therapy to minimize transfusion for major joint arthroplasty: a retrospective analysis of protocol implementation;Traitement universel à l’acide tranexamique pour minimiser les transfusions pendant toute arthroplastie majeure des articulations: une analyse rétrospective suivant la mise en œuvre d’un protocole

Canadian Journal of Anesthesia

Volumn 62, Issue 11, 2015, Pages 1179-1187

  Baker, James E ^a   Pavenski, Katerina ^a   Pirani, Razak A ^a   White, Alexander ^a   Kataoka, Mark ^a   Waddell, James P ^a   Ho, Alexander ^a   Schemitsch, Emil H ^a   Lo, Nick ^a   Bogoch, Earl R ^a   Pronovost, Antoine ^a   Luke, Katherine ^a,b   Howell, Alanna ^a,b   Nassis, Anna ^a,b   Tsui, Albert K Y ^a,c   Tanzini, Rosa Maria ^a   Pulendrarajah, Robisa ^a   Mazer, C David ^a,c   Freedman, John ^a   Hare, Gregory M T ^a,c  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b Ontario Transfusion Coordinators (ONTraC)   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

ABSENCE OF SIDE EFFECTS; ACUTE KIDNEY FAILURE; ADULT; AGED; ARTHROPLASTY; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG USE; ELECTRONIC MEDICAL RECORD; FEMALE; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEART INFARCTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; LENGTH OF STAY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; VERY ELDERLY; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; HIP REPLACEMENT; KNEE REPLACEMENT; STATISTICS AND NUMERICAL DATA;

AGED; ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TRANEXAMIC ACID;

EID: 84943365994     PISSN: 0832610X     EISSN: 14968975     Source Type: Journal    
DOI: 10.1007/s12630-015-0460-6     Document Type: Article

References (34)

1. Ker K, Edwards P, Perel P, Shakur H, Roberts I. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ 2012; 344: e3054.
2. Orpen NM, Little C, Walker G, Crawfurd EJ. Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients. Knee 2006; 13: 106-10.
3. McConnell JS, Shewale S, Munro NA, Shah K, Deakin AH, Kinninmonth AW. Reduction of blood loss in primary hip arthroplasty with tranexamic acid or fibrin spray. Acta Orthop 2011; 82: 660-3.
4. Johansson T, Pettersson LG, Lisander B. Tranexamic acid in total hip arthroplasty saves blood and money: a randomized, double-blind study in 100 patients. Acta Orthop 2005; 76: 314-9.
5. Husted H, Blond L, Sonne-Holm S, Holm G, Jacobsen TW, Gebuhr P. Tranexamic acid reduces blood loss and blood transfusions in primary total hip arthroplasty: a prospective randomized double-blind study in 40 patients. Acta Orthop Scand 2003; 74: 665-9.
6. Benoni G, Fredin H. Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients. J Bone Joint Surg Br 1996; 78: 434-40.
7. Gandhi R, Evans HM, Mahomed SR, Mahomed NN. Tranexamic acid and the reduction of blood loss in total knee and hip arthroplasty: a meta-analysis. BMC Res Notes 2013; 6: 184.
8. Panteli M, Papakostidis C, Dahabreh Z, Giannoudis PV. Topical tranexamic acid in total knee replacement: a systematic review and meta-analysis. Knee 2013; 20: 300-9.
9. Kagoma YK, Crowther MA, Douketis J, Bhandari M, Eikelboom J, Lim W. Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials. Thromb Res 2009; 123: 687-96.
10. Cid J, Lozano M. Tranexamic acid reduces allogeneic red cell transfusions in patients undergoing total knee arthroplasty: results of a meta-analysis of randomized controlled trials. Transfusion 2005; 45: 1302-7.
11. Zufferey P, Merquiol F, Laporte S, et al. Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery? Anesthesiology 2006; 105: 1034-46.
12. Ralley FE, Berta D, Binns V, Howard J, Naudie DD. One intraoperative dose of tranexamic acid for patients having primary hip or knee arthroplasty. Clin Orthop Relat Res 2010; 468: 1905-11.
13. Poeran J, Rasul R, Suzuki S, et al. Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety. BMJ 2014; 349: g4829.
14. Graham ID, Alvarez G, Tetroe J, McAuley L, Laupacis A. Factors influencing the adoption of blood alternatives to minimize allogeneic transfusion: the perspective of eight Ontario hospitals. Can J Surg 2002; 45: 132-40.
15. Tanaka N, Sakahashi H, Sato E, Hirose K, Ishima T, Ishii S. Timing of the administration of tranexamic acid for maximum reduction in blood loss in arthroplasty of the knee. J Bone Joint Surg Br 2001; 83: 702-5.
16. Benoni G, Fredin H, Knebel R, Nilsson P. Blood conservation with tranexamic acid in total hip arthroplasty: a randomized, double-blind study in 40 primary operations. Acta Orthop Scand 2001; 72: 442-8.
17. Benoni G, Lethagen S, Nilsson P, Fredin H. Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty. Acta Orthop Scand 2000; 71: 250-4.
18. Gruen RL, Reade MC. Administer tranexamic acid early to injured patients at risk of substantial bleeding. BMJ 2012; 345: e7133.
19. Salam A, King C, Orhan O, Mak V. The great deception: tranexamic acid and extensive pulmonary emboli. BMJ Case Rep 2013; 2013. pii: bcr2012007808.
20. Fergusson DA, Hebert PC, Mazer CD, et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 2008; 358: 2319-31.
21. Wong J, Abrishami A, El Beheiry H, et al. Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. J Bone Joint Surg Am 2010; 92: 2503-13.
22. Goodnough LT, Shander A. Patient blood management. Anesthesiology 2012; 116: 1367-76.
23. Moskowitz DM, McCullough JN, Shander A, et al. The impact of blood conservation on outcomes in cardiac surgery: is it safe and effective? Ann Thorac Surg 2010; 90: 451-8.
24. Hare GM, Freedman J, Mazer CD. Review article: risks of anemia and related management strategies: can perioperative blood management improve patient safety? Can J Anesth 2013; 60: 168-75.
25. Shander AS, Goodnough LT. Blood transfusion as a quality indicator in cardiac surgery. JAMA 2010; 304: 1610-1.
26. Beattie WS, Wijeysundera DN, Karkouti K, et al. Acute surgical anemia influences the cardioprotective effects of beta-blockade: a single-center, propensity-matched cohort study. Anesthesiology 2010; 112: 25-33.
27. Carrascal Y, Maroto L, Rey J, et al. Impact of preoperative anemia on cardiac surgery in octogenarians. Interact Cardiovasc Thorac Surg 2010; 10: 249-55.
28. Dunne JR, Malone D, Tracy JK, Gannon C, Napolitano LM. Perioperative anemia: an independent risk factor for infection, mortality, and resource utilization in surgery. J Surg Res 2002; 102: 237-44.
29. Goodnough LT, Shander A, Spivak JL, et al. Detection, evaluation, and management of anemia in the elective surgical patient. Anesth Analg 2005; 101: 1858-61.
30. Karkouti K, Wijeysundera DN. Beattie WS; Reducing Bleeding in Cardiac Surgery (RBC) Investigators. Risk associated with preoperative anemia in cardiac surgery: a multicenter cohort study. Circulation 2008; 117: 478-84.
31. Carson JL, Duff A, Poses RM, et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 1996; 348: 1055-60.
32. Shander A, Javidroozi M, Ozawa S, Hare GM. What is really dangerous: anaemia or transfusion? Br J Anaesth 2011; 107 Suppl 1:i41-i59: i41-59.
33. Ashes C, Judelman S, Wijeysundera DN, et al. Selective beta1-antagonism with bisoprolol is associated with fewer postoperative strokes than atenolol or metoprolol: a single-center cohort study of 44,092 consecutive patients. Anesthesiology 2013; 119: 777-87.
34. Beattie WS, Karkouti K, Wijeysundera DN, Tait G. Risk associated with preoperative anemia in noncardiac surgery: a single-center cohort study. Anesthesiology 2009; 110: 574-81.